JOHNSON & JOHNSON

Q4 2024 13F Holdings

  • Location
    new brunswick, NJ
  • Num holdings

    20

  • Value ($000)

    $386,127

  • Date Filed
    02/13/2025
  • Form type
    13F-HR
  • CIK
    0000200406
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
PTGX
PTGX

Protagonist Therapeutics Inc.

COM
74366E102
$94.54M
25 %

2,449,183

CVRX
CVRX

CVRx, Inc.

COM
126638105
$51.99M
14 %

4,103,430

RAPP
RAPP

Rapport Therapeutics, Inc.

COM
75383L102
$44.32M
12 %

2,498,051

---

MeiraGTx Holdings plc

COM
G59665102
$40.44M
11 %

6,641,064

CTNM
CTNM

Contineum Therapeutics Inc.

CL A
21217B100
$28.99M
8 %

1,979,173

PRCT
PRCT

Procept BioRobotics Corporation

COM
74276L105
$28.82M
8 %

357,939

LEGN
LEGN

Legend Biotech Corporation

SPONSORED ADS
52490G102
$26.51M
7 %

814,586

---

Neumora Therapeutics, Inc.

COM
640979100
$19.60M
5 %

1,849,445

XNCR
XNCR

Xencor, Inc.

COM
98401F105
$17.19M
5 %

748,062

NBTX
NBTX

Nanobiotix S.A.

SPONSORED ADS
63009J107
$16.14M
4 %

5,623,816

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 20